Periodically repeated rituximab administrations in children with refractory nephrotic syndrome: 2-year multicenter observational study-Reference-Cited by-同舟云学术

Periodically repeated rituximab administrations in children with refractory nephrotic syndrome: 2-year multicenter observational study

Published:2018-08-23 Issue:1 Volume:34 Page:87-96
ISSN:0931-041X
Container-title:Pediatric Nephrology
language:en
Short-container-title:Pediatr Nephrol

Author:

Takahashi Toshiyuki,Okamoto Takayuki^ORCID,Sato Yasuyuki,Yamazaki Takeshi,Hayashi Asako,Aoyagi Hayato,Ueno Michihiko,Kobayashi Norio,Uetake Kimiaki,Nakanishi Masanori,Ariga Tadashi

Publisher

Springer Science and Business Media LLC

Subject

Nephrology,Pediatrics, Perinatology, and Child Health

Link

http://link.springer.com/article/10.1007/s00467-018-4063-7/fulltext.html

Reference35 articles.

1. Iijima K, Sako M, Nozu K (2017) Rituximab for nephrotic syndrome in children. Clin Exp Nephrol 21:193–202. https://doi.org/10.1007/s10157-016-1313-5

2. Ravani P, Bonanni A, Rossi R, Caridi G, Ghiggeri GM (2016) Anti-CD20 antibodies for idiopathic nephrotic syndrome in children. Clin J Am Soc Nephrol 11:710–720. https://doi.org/10.2215/cjn.08500815

3. Sellier-Leclerc AL, Baudouin V, Kwon T, Macher MA, Guerin V, Lapillonne H, Deschenes G, Ulinski T (2012) Rituximab in steroid-dependent idiopathic nephrotic syndrome in childhood—follow-up after CD19 recovery. Nephrol Dial Transplant 27:1083–1089. https://doi.org/10.1093/ndt/gfr405

4. Ravani P, Ponticelli A, Siciliano C, Fornoni A, Magnasco A, Sica F, Bodria M, Caridi G, Wei C, Belingheri M, Ghio L, Merscher-Gomez S, Edefonti A, Pasini A, Montini G, Murtas C, Wang X, Muruve D, Vaglio A, Martorana D, Pani A, Scolari F, Reiser J, Ghiggeri GM (2013) Rituximab is a safe and effective long-term treatment for children with steroid and calcineurin inhibitor-dependent idiopathic nephrotic syndrome. Kidney Int 84:1025–1033. https://doi.org/10.1038/ki.2013.211

5. Iijima K, Sako M, Nozu K, Mori R, Tuchida N, Kamei K, Miura K, Aya K, Nakanishi K, Ohtomo Y, Takahashi S, Tanaka R, Kaito H, Nakamura H, Ishikura K, Ito S, Ohashi Y (2014) Rituximab for childhood-onset, complicated, frequently relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicentre, double-blind, randomised, placebo-controlled trial. Lancet 384:1273–1281. https://doi.org/10.1016/s0140-6736(14)60541-9

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of long-term repeated use of rituximab in pediatric patients with nephrotic syndrome;Pediatric Nephrology;2023-09-08

2. A Systematic Review and Meta-analysis of Rituximab-Associated Infections Among Children and Adolescents With Glomerular Disease: Focus on the Risk of Infections;The Journal of Pediatric Pharmacology and Therapeutics;2023-08-01

3. Efficacy and safety of long-term repeated use of rituximab in pediatric patients with nephrotic syndrome;2023-05-17

4. Changes in bone turnover markers after discontinuing long-term glucocorticoid administration in children with idiopathic nephrotic syndrome: a multicenter retrospective observational study;Pediatric Nephrology;2023-04-13

5. Use of Rituximab in Childhood Idiopathic Nephrotic Syndrome;Clinical Journal of the American Society of Nephrology;2023-02-22